In this blog at Channel 4 News, Victoria Macdonald reports on continuing delays in access to hepatitis C treatments and concerns that NHS England is seeking to influence NICE decisions about new hepatitis C treatments on the basis on affordability, rather than cost-effectiveness: Officials at NHS England have been accused of interfering in a process to